Loading research…
Identifai Genetics Limited (ASX: ID1)
Identifai Genetics Limited trades on ASX under the symbol ID1, quoted in AUD. The listing is associated with Australia. Its sector is Health technology, within Biotechnology. Reported figures retain their financial periods. Market prices and charts are shown separately from dated research.
- Exchange
- ASX
- Country
- Australia
- Sector
- Health technology
- Industry
- Biotechnology
- Trading currency
- AUD
- ISIN
- AU0000488983
Reported financials
Research date October 28, 2026. Figures below are dated observations, not market quotes.
| Metric | Value | Period | Period end |
|---|---|---|---|
| Revenue | 0.00 USD | TTM | Jul 31, 2026 |
| Net income | -3,433,258.09 USD | TTM | Jul 31, 2026 |
| Diluted EPS | -0.02 USD | TTM | Jul 31, 2026 |
| Total assets | 1,656,993.33 USD | Annual | Dec 31, 2025 |
| Total debt | 28,016.80 USD | Annual | Dec 31, 2025 |
| Return on equity | -5,750.77% | Annual | Dec 31, 2025 |
| Return on assets | -101.63% | Annual | Dec 31, 2025 |
Stock ScreenerEarnings CalendarDividends CalendarStock investing guide
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.